|
1
|
Hirata Y: Cardiopulmonary bypass for
pediatric cardiac surgery. Gen Thorac Cardiovasc Surg. 66:65–70.
2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Evora PR, Bottura C, Arcêncio L,
Albuquerque AA, Évora PM and Rodrigues AJ: Key Points for Curbing
Cardiopulmonary Bypass Inflammation. Acta Cir Bras. 31 (Suppl
1):45–52. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Chawla BK and Teitelbaum DH: Profound
systemic inflammatory response syndrome following non-emergent
intestinal surgery in children. J Pediatr Surg. 48:1936–1940.
2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Osuka A, Kusuki H, Matsuura H, Shimizu K,
Ogura H and Ueyama M: Acute intestinal damage following severe burn
correlates with the development of multiple organ dysfunction
syndrome: A prospective cohort study. Burns. 43:824–829.
2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Geissler HJ, Fischer UM, Grunert S,
Kuhn-Régnier F, Hoelscher A, Schwinger RH, Mehlhorn U and Hekmat K:
Incidence and outcome of gastrointestinal complications after
cardiopulmonary bypass. Interact Cardiovasc Thorac Surg. 5:239–242.
2006.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hashemzadeh K and Hashemzadeh S:
Predictors and outcome of gastrointestinal complications after
cardiac surgery. Minerva Chir. 67:327–335. 2012.PubMed/NCBI
|
|
7
|
De Hert S and Moerman A: Myocardial injury
and protection related to cardiopulmonary bypass. Best Pract Res
Clin Anaesthesiol. 29:137–149. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Nan Z, Jin Z, Huijuan C, Tiezheng Z and
Keyan C: Effects of TLR3 and TLR9 signaling pathway on brain
protection in rats undergoing sevoflurane pretreatment during
cardiopulmonary bypass. BioMed Res Int.
2017(4286738)2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Sun YJ, Cao HJ, Jin Q, Diao YG and Zhang
TZ: Effects of penehyclidine hydrochloride on rat intestinal
barrier function during cardiopulmonary bypass. World J
Gastroenterol. 17:2137–2142. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Riddington DW, Venkatesh B, Boivin CM,
Bonser RS, Elliott TS, Marshall T, Mountford PJ and Bion JF:
Intestinal permeability, gastric intramucosal pH, and systemic
endotoxemia in patients undergoing cardiopulmonary bypass. JAMA.
275:1007–1012. 1996.PubMed/NCBI
|
|
11
|
Tu IH, Yen HT, Cheng HW and Chiu JH:
Baicalein protects chicken embryonic cardiomyocyte against
hypoxia-reoxygenation injury via mu- and delta- but not
kappa-opioid receptor signaling. Eur J Pharmacol. 588:251–258.
2008.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Cheng L, Ma S, Wei LX, Guo HT, Huang LY,
Bi H, Fan R, Li J, Liu YL, Wang YM, et al: Cardioprotective and
antiarrhythmic effect of U50,488H in ischemia/reperfusion rat
heart. Heart Vessels. 22:335–344. 2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lin JY, Hung LM, Lai LY and Wei FC:
Kappa-opioid receptor agonist protects the microcirculation of
skeletal muscle from ischemia reperfusion injury. Ann Plast Surg.
61:330–336. 2008.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Husain S, Liou GI and Crosson CE: Opioid
receptor activation: Suppression of ischemia/reperfusion-induced
production of TNF-α in the retina. Invest Ophthalmol Vis Sci.
52:2577–2583. 2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lishmanov AY, Maslov LN, Lasukova TV,
Crawford D and Wong TM: Activation of kappa-opioid receptor as a
method for prevention of ischemic and reperfusion arrhythmias: Role
of protein kinase C and K(ATP) channels. Bull Exp Biol Med.
143:187–190. 2007.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Valtchanova-Matchouganska A, Missankov A
and Ojewole JA: Evaluation of the antidysrhythmic effects of delta-
and kappa-opioid receptor agonists and antagonists on calcium
chloride-, adrenaline- and ischemia/reperfusion-induced arrhythmias
in rats. Methods Find Exp Clin Pharmacol. 26:31–38. 2004.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sun X, Ma S, Zang YM, Lu SY, Guo HT, Bi H,
Wang YM, Ma H, Ma XL and Pei JM: Vasorelaxing effect of U50,488H in
pulmonary artery and underlying mechanism in rats. Life Sci.
78:2516–2522. 2006.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhang L, Li J, Shi Q, Fan R, Kaye AJ, Wang
Y, Sun X, Rivera FB, Kaye AD and Pei J: Role of κ-opioid receptor
in hypoxic pulmonary artery hypertension and its underlying
mechanism. Am J Ther. 20:329–336. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Koyasu S, Kobayashi M, Goto Y, Hiraoka M
and Harada H: Regulatory mechanisms of hypoxia-inducible factor 1
activity: Two decades of knowledge. Cancer Sci. 109:560–571.
2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Anju TR and Paulose CS: Amelioration of
hypoxia-induced striatal 5-HT(2A) receptor, 5-HT transporter and
HIF1 alterations by glucose, oxygen and epinephrine in neonatal
rats. Neurosci Lett. 502:129–132. 2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Barben M, Schori C, Samardzija M and Grimm
C: Targeting Hif1a rescues cone degeneration and prevents
subretinal neovascularization in a model of chronic hypoxia. Mol
Neurodegener. 13(12)2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chen Z, Wang C, Yu N, Si L, Zhu L, Zeng A,
Liu Z and Wang X: INF2 regulates oxidative stress-induced apoptosis
in epidermal HaCaT cells by modulating the HIF1 signaling pathway.
Biomed Pharmacother. 111:151–161. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kappler M, Taubert H, Schubert J,
Vordermark D and Eckert AW: The real face of HIF1α in the tumor
process. Cell Cycle. 11:3932–3936. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
24
|
Requejo-Aguilar R, Lopez-Fabuel I,
Fernandez E, Martins LM, Almeida A and Bolaños JP: PINK1 deficiency
sustains cell proliferation by reprogramming glucose metabolism
through HIF1. Nat Commun. 5(4514)2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Urrutia AA and Aragonés J: HIF oxygen
sensing pathways in lung biology. Biomedicines.
6(E68)2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Cao M, Wang P, Sun C, He W and Wang F:
Amelioration of IFN-γ and TNF-α-induced intestinal epithelial
barrier dysfunction by berberine via suppression of MLCK-MLC
phosphorylation signaling pathway. PLoS One.
8(e61944)2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wu C, Wang X, Jiang T, Li C, Zhang L, Gao
X, Tian F, Li N and Li J: Partial enteral nutrition mitigated
ischemia/reperfusion-induced damage of rat small intestinal
barrier. Nutrients. 8(E502)2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kuschel A, Simon P and Tug S: Functional
regulation of HIF-1α under normoxia--is there more than
post-translational regulation? J Cell Physiol. 227:514–524.
2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Nechemia-Arbely Y, Khamaisi M, Rosenberger
C, Koesters R, Shina A, Geva C, Shriki A, Klaus S, Rosen S,
Rose-John S, et al: In vivo evidence suggesting reciprocal renal
hypoxia-inducible factor-1 upregulation and signal transducer and
activator of transcription 3 activation in response to hypoxic and
non-hypoxic stimuli. Clin Exp Pharmacol Physiol. 40:262–272.
2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Mi Z, Rapisarda A, Taylor L, Brooks A,
Creighton-Gutteridge M, Melillo G and Varesio L: Synergystic
induction of HIF-1alpha transcriptional activity by hypoxia and
lipopolysaccharide in macrophages. Cell Cycle. 7:232–241.
2008.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Collins D, Powell G and Davies I: Cerebral
activity prior to motion task performance: An
electroencephalographic study. J Sports Sci. 9:313–324.
1991.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Szeto HH, Soong Y, Wu D and Fasolo J:
Resensitization of blood pressure response to mu-opioid peptide
agonists after acute desensitization. Anesth Analg. 93:581–586.
2001.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhou J, Zhou N, Wu XN, Cao HJ, Sun YJ,
Zhang TZ, Chen KY and Yu DM: Role of the Toll-like receptor 3
signaling pathway in the neuroprotective effect of sevoflurane
pre-conditioning during cardiopulmonary bypass in rats. Mol Med
Rep. 12:7859–7868. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
De Backer D, Hollenberg S, Boerma C,
Goedhart P, Büchele G, Ospina-Tascon G, Dobbe I and Ince C: How to
evaluate the microcirculation: Report of a round Table conference.
Crit Care. 11(R101)2007.PubMed/NCBI View
Article : Google Scholar
|
|
35
|
Sun YJ, Chen WM, Zhang TZ, Cao HJ and Zhou
J: Effects of cardiopulmonary bypass on tight junction protein
expressions in intestinal mucosa of rats. World J Gastroenterol.
14:5868–5875. 2008.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Sawada N, Murata M, Kikuchi K, Osanai M,
Tobioka H, Kojima T and Chiba H: Tight junctions and human
diseases. Med Electron Microsc. 36:147–156. 2003.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Oliver KM, Taylor CT and Cummins EP:
Hypoxia. Regulation of NFkappaB signalling during inflammation: The
role of hydroxylases. Arthritis Res Ther. 11(215)2009.PubMed/NCBI View
Article : Google Scholar
|
|
38
|
Hart ML, Henn M, Köhler D, Kloor D,
Mittelbronn M, Gorzolla IC, Stahl GL and Eltzschig HK: Role of
extracellular nucleotide phosphohydrolysis in intestinal
ischemia-reperfusion injury. FASEB J. 22:2784–2797. 2008.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Yang S, Yu M, Sun L, Xiao W, Yang X, Sun
L, Zhang C, Ma Y, Yang H, Liu Y, et al: Interferon-γ-induced
intestinal epithelial barrier dysfunction by NF-κB/HIF-1α pathway.
J Interferon Cytokine Res. 34:195–203. 2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Doguet F, Litzler PY, Tamion F, Richard V,
Hellot MF, Thuillez C, Tabley A, Bouchart F and Bessou JP: Changes
in mesenteric vascular reactivity and inflammatory response after
cardiopulmonary bypass in a rat model. Ann Thorac Surg.
77:2130–2137; author reply 2137. 2004.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Adamik B, Kübler A, Gozdzik A and Gozdzik
W: Prolonged cardiopulmonary bypass is a risk factor for intestinal
ischaemic damage and endotoxaemia. Heart Lung Circ. 26:717–723.
2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Bronicki RA and Hall M: Cardiopulmonary
bypass-induced inflammatory response: Pathophysiology and
treatment. Pediatr Crit Care Med. 17 (Suppl 1):S272–S278.
2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Hedner T and Cassuto J: Opioids and opioid
receptors in peripheral tissues. Scand J Gastroenterol Suppl. 130
(sup130):27–46. 1987.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Holzer P: Opioid receptors in the
gastrointestinal tract. Regul Pept. 155:11–17. 2009.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Liu LJ, Yu JJ and Xu XL: Kappa-opioid
receptor agonist U50448H protects against renal
ischemia-reperfusion injury in rats via activating the PI3K/Akt
signaling pathway. Acta Pharmacol Sin. 39:97–106. 2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Zhang S, Zhou Y, Zhao L, Tian X, Jia M, Gu
X, Feng N, An R, Yang L, Zheng G, et al: κ-opioid receptor
activation protects against myocardial ischemia-reperfusion injury
via AMPK/Akt/eNOS signaling activation. Eur J Pharmacol.
833:100–108. 2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Zhu Y and Pintar JE: Expression of opioid
receptors and ligands in pregnant mouse uterus and placenta. Biol
Reprod. 59:925–932. 1998.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Tsibulnikov SY, Maslov LN, Mukhomedzyanov
AV, Krylatov AV, Tsibulnikova MR and Lishmanov YB: Prospects of
using of κ-opioid receptor agonists U-50,488 and ICI 199,441 for
improving heart resistance to ischemia/reperfusion. Bull Exp Biol
Med. 159:718–721. 2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Xin J, Zhang Y, He Z and Wang Z: Highly
selective non-opioid kappa opioid receptor (KOR) agonist salvinorin
A protects against forebrain ischemia-induced brain injury in rats.
Brain Res. 1637:168–176. 2016.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Fraessdorf J, Hollmann MW, Hanschmann I,
Heinen A, Weber NC, Preckel B and Huhn R: Role of Endogenous Opioid
System in Ischemic-Induced Late Preconditioning. PLoS One.
10(e0134283)2015.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Maslov LN, Lishmanov YB, Oeltgen PR,
Barzakh EI, Krylatov AV, Naryzhnaya NV, Pei JM and Brown SA:
Comparative analysis of the cardioprotective properties of opioid
receptor agonists in a rat model of myocardial infarction. Acad
Emerg Med. 17:1239–1246. 2010.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Rong F, Peng Z, Ye MX, Zhang QY, Zhao Y,
Zhang SM, Guo HT, Hui B, Wang YM, Liang C, et al: Myocardial
apoptosis and infarction after ischemia/reperfusion are attenuated
by kappa-opioid receptor agonist. Arch Med Res. 40:227–234.
2009.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Hoesel B and Schmid JA: The complexity of
NF-κB signaling in inflammation and cancer. Mol Cancer.
12(86)2013.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Aziz RS, Siddiqua A, Shahzad M, Shabbir A
and Naseem N: Oxyresveratrol ameliorates ethanol-induced gastric
ulcer via downregulation of IL-6, TNF-α, NF-κB, and COX-2 levels,
and up-regulation of TFF-2 levels. Biomed Pharmacother.
110:554–560. 2019.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Piao H, Choi YH, Li H, Wang C, Xian Z,
Ogasawara M, Jiang J, Li L, Yamauchi K and Yan G: Recombinant pyrin
domain protein attenuates allergic inflammation by suppressing
NF-κB pathway in asthmatic mice. Scand J Immunol.
89(e12720)2019.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Café-Mendes CC, Garay-Malpartida HM, Malta
MB, de Sá Lima L, Scavone C, Ferreira ZS, Markus RP and Marcourakis
T: Chronic nicotine treatment decreases LPS signaling through NF-κB
and TLR-4 modulation in the hippocampus. Neurosci Lett.
636:218–224. 2017.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Liu Y, Yang J, Bao J, Li X, Ye A, Zhang G
and Liu H: Activation of the cholinergic anti-inflammatory pathway
by nicotine ameliorates lipopolysaccharide-induced
preeclampsia-like symptoms in pregnant rats. Placenta. 49:23–32.
2017.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Chen K, Sun Y, Diao Y, Ji L, Song D and
Zhang T: α7 nicotinic acetylcholine receptor agonist inhibits the
damage of rat hippocampal neurons by TLR4/Myd88/NF-κB signaling
pathway during cardiopulmonary bypass. Mol Med Rep. 16:4770–4776.
2017.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Zhao YX, He W, Jing XH, Liu JL, Rong PJ,
Ben H, Liu K and Zhu B: Transcutaneous auricular vagus nerve
stimulation protects endotoxemic rat from
lipopolysaccharide-induced inflammation. Evid Based Complement
Alternat Med. 2012(627023)2012.PubMed/NCBI View Article : Google Scholar
|
